Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam IM vs Oral in Osteoarthritis
NCT00239395Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meloxicam in osteoarthritis (OA), sponsored by Boehringer Ingelheim. Started Jul 2004; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00239395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239395.